These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25684487)

  • 1. Assessment of the reliability of a novel self-sampling device for performing cervical sampling in Malaysia.
    Latiff LA; Rahman SA; Wee WY; Dashti S; Andi Asri AA; Unit NH; Siah Li SF; Esfehani AJ; Ahmad S
    Asian Pac J Cancer Prev; 2015; 16(2):559-64. PubMed ID: 25684487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Assessment of a Self-sampling Device and Gynecologist Sampling for Cytology and HPV DNA Detection in a Rural and Low Resource Setting: Malaysian Experience.
    Latiff LA; Ibrahim Z; Pei CP; Rahman SA; Akhtari-Zavare M
    Asian Pac J Cancer Prev; 2015; 16(18):8495-501. PubMed ID: 26745108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.
    El-Zein M; Bouten S; Louvanto K; Gilbert L; Gotlieb W; Hemmings R; Behr MA; Franco EL;
    Gynecol Oncol; 2018 Jun; 149(3):491-497. PubMed ID: 29678360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
    Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
    Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of HPV testing of vaginal smear obtained with a novel self-sampling device.
    Stenvall H; Wikström I; Backlund I; Wilander E
    Acta Obstet Gynecol Scand; 2007; 86(1):16-21. PubMed ID: 17230283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
    Aarnio R; Östensson E; Olovsson M; Gustavsson I; Gyllensten U
    BMC Cancer; 2020 Jul; 20(1):645. PubMed ID: 32660432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.
    Nobbenhuis MA; Helmerhorst TJ; van den Brule AJ; Rozendaal L; Jaspars LH; Voorhorst FJ; Verheijen RH; Meijer CJ
    J Clin Pathol; 2002 Jun; 55(6):435-9. PubMed ID: 12037026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CyclinA1 Promoter Methylation in Self-Sampling Test.
    Oranratanaphan S; Kengsakul M; Triratanachat S; Kitkumthorn N; Mutirangura A; Termrungruanglert W
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2913-2917. PubMed ID: 33112548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network Across Rural Greece: The GRECOSELF Study.
    Agorastos T; Chatzistamatiou K; Tsertanidou A; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moysiadis T; Moschaki V; Skenderi A; Katsiki E; Aggelidou S; Venizelos I; Ntoula M; Daponte A; Vanakara P; Garas A; Stefos T; Vrekoussis T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Manidakis G; Deligeoroglou E; Panoskaltsis T; Decavalas GO; Michail G; Kalogiannidis I; Koukoulis G; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Chronopoulou A; Vaitsi V; Chatzaki E; Paschopoulos M; Adonakis G; Kaufmann AM; Hadzidimitriou A; Stamatopoulos K
    Cancer Prev Res (Phila); 2019 Oct; 12(10):701-710. PubMed ID: 31427275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk human papillomavirus messenger RNA testing in physician- and self-collected specimens for cervical lesion detection in high-risk women, Kenya.
    Ting J; Mugo N; Kwatampora J; Hill C; Chitwa M; Patel S; Gakure H; Kimani J; Schoenbach VJ; Poole C; Smith JS
    Sex Transm Dis; 2013 Jul; 40(7):584-9. PubMed ID: 23965776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.
    Nieves L; Enerson CL; Belinson S; Brainard J; Chiesa-Vottero A; Nagore N; Booth C; Pérez AG; Chávez-Avilés MN; Belinson J
    Int J Gynecol Cancer; 2013 Mar; 23(3):513-8. PubMed ID: 23334437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge.
    Geraets DT; van Baars R; Alonso I; Ordi J; Torné A; Melchers WJ; Meijer CJ; Quint WG
    J Clin Virol; 2013 Jun; 57(2):125-9. PubMed ID: 23518442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of detection sensitivity for human papillomavirus between self-collected vaginal swabs and physician-collected cervical swabs by electrochemical DNA chip.
    Nilyanimit P
    Asian Pac J Cancer Prev; 2014; 15(24):10809-12. PubMed ID: 25605181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-sampling versus physician-sampling for human papillomavirus testing.
    Agorastos T; Dinas K; Lloveras B; Font R; Kornegay JR; Bontis J; de Sanjose S
    Int J STD AIDS; 2005 Nov; 16(11):727-9. PubMed ID: 16303065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised study of HPV prevalence and detection of CIN2+ in vaginal self-sampling compared to cervical specimens collected by medical personnel.
    Gustavsson I; Aarnio R; Berggrund M; Hedlund-Lindberg J; Sanner K; Wikström I; Enroth S; Olovsson M; Gyllensten U
    Int J Cancer; 2019 Jan; 144(1):89-97. PubMed ID: 29943822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of human papillomavirus DNA in self-administered vaginal swabs as compared to cervical swabs.
    Palmisano ME; Gaffga AM; Daigle J; Brinkman J; Mire K; Lenczyk K; Martin DH; Hagensee ME
    Int J STD AIDS; 2003 Aug; 14(8):560-7. PubMed ID: 12935387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of oncogenic human papilloma virus in women not attending organized cytological screening.
    Stenvall H; Wikström I; Wilander E
    Acta Derm Venereol; 2007; 87(3):243-5. PubMed ID: 17533491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology.
    Gustavsson I; Aarnio R; Berggrund M; Hedlund-Lindberg J; Strand AS; Sanner K; Wikström I; Enroth S; Olovsson M; Gyllensten U
    Br J Cancer; 2018 Mar; 118(6):896-904. PubMed ID: 29438367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.